NTRK2 and early-onset autosomal dominant Alzheimer disease: 7,8-Dihydroxyflavone, which is an agonist of tropomyosin-related kinase B (TrkB), a BDNF and neurotrphin-4/5 (NT-4/5) receptor, also has similar beneficial effects on Alzheimer’s disease model mice [5].